The gene encoding an extracellular metalloproteinase from Serratia sp. E-15 has been cloned, and its complete nucleotide sequence determined. The amino acid sequence deduced from the nucleotide sequence reveals that the mature protein of the Serratia protease consists of *70 amino acids with a molecular weight of 50,632. The G+C content of the coding region for the mature protein is 58 %; this high G+C content is due to a marked preference for G+C bases at the third position of the codons. The gene codes for a short pro-peptide preceding the mature protein. The Serratia protease gene was expressed in Escherichia coli and Serratia marcescens; the former produced the Serratia protease in the cells and" the latter in the culture medium. Three zinc ligands and an active site of the Serratia protease were predicted by comparing the structure of the enzyme with those of thermolysin and Bacillus subtilis neutral protease.
INTRODUCTION
In culture medium Serratia sp. E-15 produces a potent protease (1) , which is widely used as an anti-inflammatory agent. The enzyme has a zinc atom, which is essential for proteolytic activity, and its substrate specificity is somewhat similar to that of thermolysin (EC 3.4.2<f.4) produced by Bacillus thermoproteolyticus (1) (2) (3) . The molecular weight of the Serratia protease has been estimated to be «,000-60,000 by various physical methods (1,*), however, the complete amino acid sequence has not been determined. Lee et al. reported the amino acid sequences of the NH2-terminal half (278 residues) and the COOH-terminal peptide (13 residues) of the enzyme and proposed possible zinc ligands (two histidine residues) on the basis of structural similarity with thermolysin (5, 6) .
Schmitz and Braun (7) also purified an exoprotease of Serratia marcescens ATCC 25*19 and determined its NH2-terrninal (10 residues) and COOH-terminal (* residues) amino acid sequences, which are almost identical with the sequences of the Serratia protease reported by Lee et al. (5, 6) .
It has been difficult to determine the complete amino acid sequence of the Serratia protease because of the large molecular weight. We have attempted to determine the amino acid sequence from the nucleotide sequence of the Serratia protease gene. The complete nucleotide sequences of only two Serratia genes, the glutamine amidotransferase gene (8) and the chitinase gene (9) from S. marcescens, have been reported. In this paper, we describe the cloning and DNA sequencing of the protease gene from Serratia sp. E-15, and the deduced amino acid sequence of the enzyme. We also predict three zinc ligands and an active site of the enzyme by comparing the enzyme with therrnolysin (10, 11) and Bacillus subtilis protease (12, 13) .
MATERIALS AND METHODS Materials
Restriction enzymes were purchased from New England Biolabs, Takara Shuzo, or Nippon Gene. T<f DNA ligase and Escherichia coli DNA polymerase I were from New England Biolabs. T* polynucleotide kinase was from Takara Shuzo. fa- 32 PJ ATP (3000 Ci/mmol) and (tf-32 p)dCTP (>400 Ci/ mmol) were purchased from Amersham. M13
sequencing kit was from Takara Shuzo. Oligonucleotides were synthesized by the phosphoamidite method (1*) using DNA synthesizers (Genet A-II, Nippon Zeon; 380A DNA Synthesizer, Applied Biosystems). Authentic Serratia protease and rabbit antiSerratia protease antiserum were provided by Dr. K. Miyata of our Central Research Division. Bacterial strains, plasmids, and media Serratia sp. E-15 was obtained from the Institute for Fermentation, Osaka. E. coli 3M103 (15) and E. coli DH1 (16) were used as hosts. S. marcescens NC-* was provided by Dr. H. Ono of our Central Reasearch Division. Plasmid pUC12 and M13 phage vectors were purchased from P-L Biochemicals. Bacteria were grown in L-broth (17) or brain heart infusion (Difco). Isolation of DNA Chromosomal DNA of Serratia sp. E-15 was prepared as described by Lovett and Keggins (18) . Plasmid DNA was isolated by the alkaline extraction procedure (19) . Transformation E. coU 3M103 and E. coli DH1 were transformed by the CaC^/RbCl procedure (16) . In the case of.E. coli 3M103, cells were grown on L-agar containing ampicillin, 5-bromo<Khloro-3-indolyl-^-D-galactopyranoside and isopropyl-^-D-thiogalactopyranoside, and white colonies were used for colony hybridization. S. marcescens NC-f was transformed by the CaCl2 procedure (16) .
Colony hybridization
Colony hybridization was carried out as described by Maniatis et al. (16) . Transformants were transferred onto nitrocellulose filters on L-agar plates and grown overnight at 37*C. The colonies on the filters were lyzed, and the liberated DNA was fixed to the filters by baking. The synthetic oligonucleotides were labeled by phosphorylation with (f- open reading frame Is followed by a palindromic sequence, which appears to be a transcription terminator (Fig. 3) . Another open reading frame is present downstream from the putative transcription terminator (from nucleotide 2,338), although the sequence downstream from the PstI site has not yet been determined.
Expression of the Serratia protease gene
The cloned Insert in pTSP20 lacks the 3" region (about 240 bp) of the protease gene, and the one in pTSP21 lacks the promoter region. A Serratia protease expression plasmid, pTSP26, was constructed by isolating the 1.0 kb EcoRV fragment containing the promoter region of the gene from pTSP20 and ligating it with the 8.2 kb EcoRV fragment from pTSP21 (Fig. 1). E. coli harboring pTSP26 showed no detectable zone of clearing on an agar plate containing 3 % skim milk, while Serratia sp. E-15 created a large clearing zone. JM103/pBR322 (Fig. 4). S. marcescens NC-4/pTSP26 and S. marcescens NC-4 were grown as just described, and the culture supernatants were assayed for protease activity. The protease activity of S. marcescens NC-4/pTSP26 was more than twice as high as that of S. marcescens NC-4. The protease thus produced was identical with the authentic Serratia protease, as examined by the Western blotting.
DISCUSSION
Lee e_t al. determined the amino acid sequences of the NH2-terminal half and COOHterminal peptide of the Serratia protease (5,6), which is widely used for medical purposes. As described above, we have cloned the Serratia protease gene and determined its complete nucleotide sequence. The amino acid sequence deduced from the nucleotide sequence is almost identical to the partial sequence determined by Lee et al. (5,6) . There are some differences between the two determinants described above. Most of the differences are between Asn and Asp, and seem to be due to an artifact during the Edman degradation of the protein.
The Serratia protease has a zinc atom, which is essential for proteolytic activity, and its substrate specificity is somewhat similar to that of thermolysin ( (Fig. 5A) . The region from residue 305 to 315 in Serratia protease is very similar to the regions containing another zinc ligand (Glu) in thermolysin (residues 164-173) and B. subtilis neutral protease (residues 165-174), although a residue, Lys, is inserted in Serratia protease (Fig. 5B) . The region from residue 224 to 230 in Serratia protease is Gly   TGT  TGC  TGA  TGG  CGT  CGC  CGA  CGG  AGT  AGC  AGA  AGG  GGT  GGC  GGA The G+C content of chromosomal DNA from S. marcescens (59 %) is higher than that of E. coli chromosomal DNA (51 %) (33). The G+C content of the sequenced 2,570 base fragment is 54 %. Within the fragment, the coding region for the mature protein of the Serratia protease (58 %) is much more G+C-rich than the 5' noncoding region (42 %). Table II The Serratia protease has been produced in industrial scale and widely used in medical purposes. We have obtained the gene by molecular cloning. The gene will be useful for improving enzyme production and modifying the enzyme by using recombinant DNA techniques in the future.
